PPARA and nonpapillary renal cell carcinoma: In line with this, our data suggest that the proposed double-negative feedback interaction between PPAR-α and miR-21 could be therapeutically exploited to restore PPAR-α expression and consequently inhibit the oncogenic events mediated by the aberrant lipid metabolism of ccRCC.